Synthesis and Development of Indole Based 5-HT3 Receptor Antagonists as Anti-Emetic Drugs in Oncology: An Update
Keyword(s):
Type 3
◽
: An important group of anti-emetic drugs used in the treatment of nausea and vomiting after chemotherapy contains an indole moiety in their structures, working as 5-hydroxytryptamine type 3 serotonin receptor antagonist (5-HT3). This revision is focused on compounds bearing an indole core that present a 5-HT3 receptor antagonist activity that has been successfully used as anti-emetic drugs, reducing chemotherapy adverse secondary effects during cancer treatment. Their synthesis, biological activities, and some outstanding characteristics are discussed, affording a general outlook towards the development of more efficient anti-emetic drugs.
2007 ◽
Vol 13
(2)
◽
pp. 69-75
◽
Keyword(s):
1995 ◽
Vol 27
(Supplement)
◽
pp. S145
1995 ◽
Vol 29
(12)
◽
pp. 1240-1251
◽
2002 ◽
Vol 335
(8)
◽
pp. 367-373
◽
2009 ◽
Vol 11
(8)
◽
pp. 771-778
◽
2004 ◽
Vol 26
(7)
◽
pp. 515
◽